Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VRNA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Verona Pharma plc stock downgraded after the last trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Verona Pharma plc stock price fell by -2.48% on the last day (Thursday, 28th Mar 2024) from $16.50 to $16.09. During the last trading day the stock fluctuated 5.85% from a day low at $15.80 to a day high of $16.73. The price has risen in 6 of the last 10 days and is up by 3.54% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -50 thousand shares and in total, 307 thousand shares were bought and sold for approximately $4.94 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.17% during the next 3 months and, with a 90% probability hold a price between $12.51 and $14.41 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VRNA Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 19, 2024, and so far it has risen 5.16%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Verona Pharma plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $16.61. On a fall, the stock will find some support from the short-term average at $16.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Verona Pharma plc stock

Verona Pharma plc finds support from accumulated volume at $15.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.93 between high and low, or 5.85%. For the last week, the stock has had daily average volatility of 4.87%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VRNA) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Verona Pharma plc to open at $16.21, and during the day (based on 14 day Average True Range), to move between $15.26 and $16.92, which gives a possible trading interval of +/-$0.83 (+/-5.15%) up or down from last closing price. If Verona Pharma plc takes out the full calculated possible swing range there will be an estimated 10.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $15.93 (0.99%) than the resistance at $16.75 (4.10%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Verona Pharma plc stock A Buy?

Verona Pharma plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.829 Sell Candidate Downgraded

Predicted Opening Price for Verona Pharma plc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$16.21 ( 0.715%) $16.09

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VRNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.13 6.46 %
R2 16.78 4.27 %
R1 16.56 2.91 %
Current price: 16.09
Support S1 15.85 -1.48 %
S2 15.63 -2.84 %
S3 15.28 -5.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 18.83 17.03 %
R2 16.96 5.41 %
R1 16.75 4.10 %
Current price 16.09
Support S1 15.93 -0.99%
S2 15.54 -3.42%
S3 15.30 -4.91%

FAQ

What is the symbol for Verona Pharma plc Stock and on which exchange is it traded?
The symbol for Verona Pharma plc is VRNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Verona Pharma plc Stock?
Verona Pharma plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Verona Pharma plc Stock?
Verona Pharma plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Verona Pharma plc Stock.

What's the current price of Verona Pharma plc Stock?
As of the end of day on the 2024-03-28, the price of an Verona Pharma plc (VRNA) share was $16.09.

What is the 52-week high and low for Verona Pharma plc Stock?
The 52-week high for Verona Pharma plc Stock is $23.81 and the 52-week low is $11.83.

What is the market capitalization of Verona Pharma plc Stock?
As of the 2024-03-28, the market capitalization of Verona Pharma plc is 1.327B.

When is the next earnings date for Verona Pharma plc?
The upcoming earnings date for Verona Pharma plc is May 14, 2024.
Click to get the best stock tips daily for free!

About Verona Pharma plc

Verona Pharma plc Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ... VRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT